Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1944396
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1944396
Thoracic Outlet Syndrome Market, By Route of Administration, By Technology/Mode of Action, By Drug Class, By Product Type, By Application, By End-User, By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
PUBLISHED:
PAGES: 389 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Thoracic Outlet Syndrome Market size was valued at US$ 221.19 Million in 2024, expanding at a CAGR of 5.50% from 2025 to 2032.
The thoracic outlet syndrome (TOS) market includes diagnostic services, therapeutic interventions, and surgical solutions for treating nerve, vein, or artery compression in the neck and shoulder region. The increasing prevalence of repetitive strain injuries and posture-related disorders associated with sedentary lifestyles and physically demanding occupations is driving market growth. A notable trend is the shift toward minimally invasive decompression procedures, which are aided by advanced imaging and nerve monitoring technologies. However, limited awareness and frequent misdiagnosis of TOS are major barriers. Despite this, expanding rehabilitation programs, implementing ergonomic solutions, and improving clinician training offer significant opportunities to improve early diagnosis, treatment outcomes, and overall market expansion.
Thoracic Outlet Syndrome Market- Market Dynamics
Increasing Adoption of Pharmacologic Management Fuel Market Growth
The thoracic outlet syndrome market is witnessing growth due to the increasing use of pharmacologic management as a primary step before surgical intervention. Physicians are increasingly adopting medications such as anti-inflammatory agents, muscle relaxants, and pain management drugs to relieve symptoms and improve patient outcomes, especially in neurogenic TOS cases. This conservative approach helps reduce the need for invasive procedures, shortens recovery time, and supports better long-term patient compliance. The trend is further strengthened by ongoing clinical studies comparing conservative care with surgery, reinforcing the effectiveness of non-surgical treatment pathways. For instance, a July 2022 study by Maastricht University compared surgery versus continued conservative treatment in neurogenic TOS, where 50 patients initially received conservative therapy, reflecting growing adoption of pharmacologic management.
Thoracic Outlet Syndrome Market- Segmentation Analysis:
The Global Thoracic Outlet Syndrome Market is segmented on the basis of Route of Administration, Technology/Mode of Action, Drug Class, Product Type, Application, End-User, and Region.
The oral segment is in dominant position. In 2024, the oral route of administration accounted for majority of the total. The rising number of cases associated with TOS, particularly neurogenic TOS, is driving an increase in the use of oral drugs due to their convenience and availability. As a result, it became a popular choice and contributed to the segment's growth. According to the Mayo Clinic's 2023 treatment guidelines for Thoracic outlet syndrome, NSAIDs such as ibuprofen or naproxen are commonly prescribed oral medications that help to reduce inflammation and pain in patients.
The neurogenic thoracic outlet syndrome (TOS) segment remains the largest market contributor, driven by its high prevalence and rising case numbers. Neurogenic TOS is the most common form of the condition, resulting in increased demand for diagnostic services and therapeutic interventions. As per data from the National Library of Medicine (October 2022), the annual incidence of neurogenic TOS is estimated at 2-3 cases per 100,000 individuals, with a prevalence of around 10 cases per 100,000 population. This subtype represents approximately 90-95% of all TOS cases, underscoring its dominant role in shaping market dynamics.
Thoracic Outlet Syndrome Market- Geographical Insights
North America holds the significant share in the market, owing to its well-developed diagnostic center system, high use of modern imaging methods, and presence of multidisciplinary specialty centers. Clinical awareness among physicians, physiotherapists, and surgeons has resulted in earlier recognition and differentiation of neurogenic, venous, and arterial TOS. Minimally invasive surgical technologies, extensive rehabilitation programs, and well-developed reimbursement schemes all help patients get the treatment they need. Furthermore, the leaders of the medical device market and research facilities in the United States and Canada are constantly investing in better surgical instruments, computerized diagnostics, and postural examinations, confirming North America's global market dominance.
United States Thoracic Outlet Syndrome Market- Country Insights
The United States is projected to lead the North American thoracic outlet syndrome market, supported by the growing incidence of the condition among athletes and broad access to advanced healthcare infrastructure that enables timely diagnosis and effective treatment. Strong clinical capabilities and specialized care centers further reinforce the country's market position. For example, according to NIH data published in October 2024, a study was conducted to determine the burden of in-hospital admissions and outcomes of thoracic outlet compression syndrome in the United States between 2010 and 2021. It was discovered that of the 37,174 hospitalizations, 7,397 were for venous TOS, 3,346 for arterial TOS, and 26,430 for neurogenic TOS.
Thoracic Outlet Syndrome Market- Competitive Landscape:
The thoracic outlet syndrome (TOS) market is moderately competitive, with medical device manufacturers, surgical solution providers, and specialty healthcare service companies focusing on vascular, neurological, and orthopedic care. Advances in minimally invasive surgical techniques, diagnostic imaging, and postoperative rehabilitation solutions are driving competition. To strengthen their market presence, leading players focus on product innovation, clinical training, and strategic partnerships with hospitals and specialty clinics. Companies are also investing in ergonomic and nerve-monitoring technologies to improve surgical outcomes and lower complications. Medtronic, Stryker, Johnson & Johnson (Ethicon), Abbott and Smith+Nephew are key market players that provide surgical instruments, vascular solutions, and supportive technologies for TOS management.
Recent Developments:
In July 2025, Bristol-Myers Squibb Company and Pfizer Inc. announced a new direct-to-patient option for purchasing Eliquis (apixaban) through Eliquis 360 Support.
In August, 2024, Pfizer Inc. announced that the US Department of Health and Human Services has disclosed the "maximum fair price" (MFP) for ELIQUIS (apixaban).
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL THORACIC OUTLET SYNDROME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Stryker
- Globus Medical
- Becton Dickinson (BD)
- Smith and Nephew
- Hologi
- Zimmer Biomet
- Cook Medical
- Abbott
- B. Braun
- Teleflex
- Philips Healthcare
- Terumo Corporation
- Medtronic
- Cardinal Health
- Boston Scientific
- CONMED Corporation
- Johnson & Johnson (DePuy Synthes)
- Siemens Healthineers
- GE HealthCare
- Koninklijke Philips
- NuVasive
- Arthrex
- AngioDynamics
- Others
GLOBAL THORACIC OUTLET SYNDROME MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032
- Parenteral
- Oral
- Others
GLOBAL THORACIC OUTLET SYNDROME MARKET, BY TECHNOLOGY/MODE OF ACTION- MARKET ANALYSIS, 2019 - 2032
- Nerve & Vascular Decompression Tools
- Physical Rehabilitation & Manual Therapy Techniques
- Minimally Invasive Surgical Technologies
- Pharmacological Pain Management
- Imaging & Diagnostic Modalities
GLOBAL THORACIC OUTLET SYNDROME MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019 - 2032
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Anticoagulants
- Corticosteroids
- Muscle Relaxants
- Thrombolytics
- Others
GLOBAL THORACIC OUTLET SYNDROME MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Physical Therapy & Rehabilitation Solutions
- Nerve-gliding techniques
- Postural correction programs
- Pharmacological Treatments
- NSAIDs
- Neuropathic pain medications
- Muscle relaxants
- Diagnostic Imaging & Evaluation Tools
- Doppler ultrasound systems
- MRI/CT imaging systems
- Surgical Intervention Tools & Devices
- First rib resection tools
- Scalenectomy instruments
- Supportive & Adjunctive Treatment Devices
- Pain management devices
- Orthotic braces
GLOBAL THORACIC OUTLET SYNDROME MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Arterial Thoracic Outlet Syndrome
- Venous Thoracic Outlet Syndrome
- Neurogenic Thoracic Outlet Syndrome
- Mixed/Non-specified TOS Conditions
GLOBAL THORACIC OUTLET SYNDROME MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Specialty Care Centers
- Physiotherapy & Rehabilitation Clinics
- Outpatient Surgical Centers
- Diagnostic Imaging Centers
- Other End-Users
GLOBAL THORACIC OUTLET SYNDROME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV6021
Table of Contents
1. Thoracic Outlet Syndrome Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Thoracic Outlet Syndrome Market Snippet by Route of Administration
- 2.1.2. Thoracic Outlet Syndrome Market Snippet by Technology/Mode of Action
- 2.1.3. Thoracic Outlet Syndrome Market Snippet by Drug Class
- 2.1.4. Thoracic Outlet Syndrome Market Snippet by Product Type
- 2.1.5. Thoracic Outlet Syndrome Market Snippet by Application
- 2.1.6. Thoracic Outlet Syndrome Market Snippet by End-User
- 2.1.7. Thoracic Outlet Syndrome Market Snippet by Country
- 2.1.8. Thoracic Outlet Syndrome Market Snippet by Region
- 2.2. Competitive Insights
3. Thoracic Outlet Syndrome Key Market Trends
- 3.1. Thoracic Outlet Syndrome Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Thoracic Outlet Syndrome Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Thoracic Outlet Syndrome Market Opportunities
- 3.4. Thoracic Outlet Syndrome Market Future Trends
4. Thoracic Outlet Syndrome Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Thoracic Outlet Syndrome Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Thoracic Outlet Syndrome Market Landscape
- 6.1. Thoracic Outlet Syndrome Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Thoracic Outlet Syndrome Market - By Route of Administration
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
- 7.1.2. Parenteral
- 7.1.3. Oral
- 7.1.4. Others
8. Thoracic Outlet Syndrome Market - By Technology/Mode of Action
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology/Mode of Action, 2024 & 2032 (%)
- 8.1.2. Nerve & Vascular Decompression Tools
- 8.1.3. Physical Rehabilitation & Manual Therapy Techniques
- 8.1.4. Minimally Invasive Surgical Technologies
- 8.1.5. Pharmacological Pain Management
- 8.1.6. Imaging & Diagnostic Modalities
9. Thoracic Outlet Syndrome Market - By Drug Class
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
- 9.1.2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- 9.1.3. Anticoagulants
- 9.1.4. Corticosteroids
- 9.1.5. Muscle Relaxants
- 9.1.6. Thrombolytics
- 9.1.7. Others
10. Thoracic Outlet Syndrome Market - By Product Type
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 10.1.2. Physical Therapy & Rehabilitation Solutions
- 10.1.2.1. Nerve-gliding techniques
- 10.1.2.2. Postural correction programs
- 10.1.3. Pharmacological Treatments
- 10.1.3.1. NSAIDs
- 10.1.3.2. Neuropathic pain medications
- 10.1.3.3. Muscle relaxants
- 10.1.4. Diagnostic Imaging & Evaluation Tools
- 10.1.4.1. Doppler ultrasound systems
- 10.1.4.2. MRI/CT imaging systems
- 10.1.5. Surgical Intervention Tools & Devices
- 10.1.5.1. First rib resection tools
- 10.1.5.2. Scalenectomy instruments
- 10.1.6. Supportive & Adjunctive Treatment Devices
- 10.1.6.1. Pain management devices
- 10.1.6.2. Orthotic braces
11. Thoracic Outlet Syndrome Market - By Application
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 11.1.2. Arterial Thoracic Outlet Syndrome
- 11.1.3. Venous Thoracic Outlet Syndrome
- 11.1.4. Neurogenic Thoracic Outlet Syndrome
- 11.1.5. Mixed/Non-specified TOS Conditions
12. Thoracic Outlet Syndrome Market - By End-User
- 12.1. Overview
- 12.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
- 12.1.2. Hospitals & Specialty Care Centers
- 12.1.3. Physiotherapy & Rehabilitation Clinics
- 12.1.4. Outpatient Surgical Centers
- 12.1.5. Diagnostic Imaging Centers
- 12.1.6. Other End-Users
13. Thoracic Outlet Syndrome Market- By Geography
- 13.1. Introduction
- 13.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 13.2. North America
- 13.2.1. Overview
- 13.2.2. Thoracic Outlet Syndrome Key Manufacturers in North America
- 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.2.4. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.2.5. North America Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.2.6. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.2.7. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.2.9. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.2.10. U.S.
- 13.2.10.1. Overview
- 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.2.10.3. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.2.10.4. U.S. Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.2.10.5. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.2.10.6. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.2.10.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.2.10.8. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.2.11. Canada
- 13.2.11.1. Overview
- 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.2.11.3. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.2.11.4. Canada Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.2.11.5. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.2.11.6. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.2.11.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.2.11.8. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3. Europe
- 13.3.1. Overview
- 13.3.2. Thoracic Outlet Syndrome Key Manufacturers in Europe
- 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.3.4. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.5. Europe Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.6. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.7. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.9. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.10. Germany
- 13.3.10.1. Overview
- 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.10.3. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.10.4. Germany Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.10.5. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.10.6. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.10.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.10.8. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.11. UK
- 13.3.11.1. Overview
- 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.11.3. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.11.4. UK Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.11.5. UK Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.11.6. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.11.7. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.11.8. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.12. France
- 13.3.12.1. Overview
- 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.12.3. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.12.4. France Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.12.5. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.12.6. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.12.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.12.8. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.13. Italy
- 13.3.13.1. Overview
- 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.13.3. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.13.4. Italy Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.13.5. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.13.6. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.13.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.13.8. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.14. Spain
- 13.3.14.1. Overview
- 13.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.14.3. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.14.4. Spain Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.14.5. Spain Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.14.6. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.14.7. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.14.8. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.15. The Netherlands
- 13.3.15.1. Overview
- 13.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.15.3. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.15.4. The Netherlands Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.15.5. The Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.15.6. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.15.7. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.15.8. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.16. Sweden
- 13.3.16.1. Overview
- 13.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.16.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.16.4. Sweden Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.16.5. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.16.6. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.16.7. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.16.8. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.17. Russia
- 13.3.17.1. Overview
- 13.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.17.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.17.4. Russia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.17.5. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.17.6. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.17.7. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.17.8. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.18. Poland
- 13.3.18.1. Overview
- 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.18.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.18.4. Poland Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.18.5. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.18.6. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.18.7. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.18.8. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.3.19. Rest of Europe
- 13.3.19.1. Overview
- 13.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.3.19.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.3.19.4. Rest of the Europe Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.3.19.5. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.3.19.6. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.3.19.8. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4. Asia Pacific (APAC)
- 13.4.1. Overview
- 13.4.2. Thoracic Outlet Syndrome Key Manufacturers in Asia Pacific
- 13.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.4.4. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.5. APAC Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.6. APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.7. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.8. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.9. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4.10. China
- 13.4.10.1. Overview
- 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.10.3. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.10.4. China Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.10.5. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.10.6. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.10.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.10.8. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4.11. India
- 13.4.11.1. Overview
- 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.11.3. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.11.4. India Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.11.5. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.11.6. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.11.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.11.8. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4.12. Japan
- 13.4.12.1. Overview
- 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.12.3. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.12.4. Japan Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.12.5. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.12.6. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.12.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.12.8. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4.13. South Korea
- 13.4.13.1. Overview
- 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.13.3. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.13.4. South Korea Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.13.5. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.13.6. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.13.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.13.8. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4.14. Australia
- 13.4.14.1. Overview
- 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.14.3. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.14.4. Australia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.14.5. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.14.6. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.14.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.14.8. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4.15. Indonesia
- 13.4.15.1. Overview
- 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.15.3. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.15.4. Indonesia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.15.5. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.15.6. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.15.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.15.8. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4.16. Thailand
- 13.4.16.1. Overview
- 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.16.3. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.16.4. Thailand Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.16.5. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.16.6. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.16.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.16.8. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4.17. Philippines
- 13.4.17.1. Overview
- 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.17.3. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.17.4. Philippines Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.17.5. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.17.6. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.17.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.17.8. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.4.18. Rest of APAC
- 13.4.18.1. Overview
- 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.4.18.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.4.18.4. Rest of APAC Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.4.18.5. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.4.18.6. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.4.18.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.4.18.8. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.5. Latin America (LATAM)
- 13.5.1. Overview
- 13.5.2. Thoracic Outlet Syndrome Key Manufacturers in Latin America
- 13.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.5.4. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.5.5. LATAM Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.5.6. LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.5.7. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.5.8. LATAM Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.9. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.5.10. Brazil
- 13.5.10.1. Overview
- 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.10.3. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.5.10.4. Brazil Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.5.10.5. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.5.10.6. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.5.10.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.10.8. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.5.11. Mexico
- 13.5.11.1. Overview
- 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.11.3. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.5.11.4. Mexico Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.5.11.5. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.5.11.6. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.5.11.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.11.8. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.5.12. Argentina
- 13.5.12.1. Overview
- 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.12.3. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.5.12.4. Argentina Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.5.12.5. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.5.12.6. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.5.12.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.12.8. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.5.13. Colombia
- 13.5.13.1. Overview
- 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.13.3. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.5.13.4. Colombia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.5.13.5. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.5.13.6. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.5.13.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.13.8. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.5.14. Rest of LATAM
- 13.5.14.1. Overview
- 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.5.14.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.5.14.4. Rest of LATAM Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.5.14.5. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.5.14.6. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.5.14.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.5.14.8. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.6. Middle East and Africa
- 13.6.1. Overview
- 13.6.2. Thoracic Outlet Syndrome Key Manufacturers in Middle East and Africa
- 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 13.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.6.5. Middle East and Africa Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.6.6. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.6.7. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.9. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.6.10. Saudi Arabia
- 13.6.10.1. Overview
- 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.10.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.6.10.4. Saudi Arabia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.6.10.5. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.6.10.6. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.6.10.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.10.8. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.6.11. United Arab Emirates
- 13.6.11.1. Overview
- 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.11.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.6.11.4. United Arab Emirates Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.6.11.5. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.6.11.6. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.6.11.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.11.8. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.6.12. Israel
- 13.6.12.1. Overview
- 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.12.3. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.6.12.4. Israel Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.6.12.5. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.6.12.6. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.6.12.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.12.8. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.6.13. Turkey
- 13.6.13.1. Overview
- 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.13.3. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.6.13.4. Turkey Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.6.13.5. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.6.13.6. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.6.13.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.13.8. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.6.14. Algeria
- 13.6.14.1. Overview
- 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.14.3. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.6.14.4. Algeria Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.6.14.5. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.6.14.6. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.6.14.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.14.8. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.6.15. Egypt
- 13.6.15.1. Overview
- 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.15.3. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.6.15.4. Egypt Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.6.15.5. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.6.15.6. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.6.15.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.15.8. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 13.6.16. Rest of MEA
- 13.6.16.1. Overview
- 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 13.6.16.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 13.6.16.4. Rest of MEA Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
- 13.6.16.5. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
- 13.6.16.6. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 13.6.16.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 13.6.16.8. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
14. Key Vendor Analysis- Thoracic Outlet Syndrome Industry
- 14.1. Competitive Benchmarking
- 14.1.1. Competitive Dashboard
- 14.1.2. Competitive Positioning
- 14.2. Company Profiles
- 14.2.1. Stryker
- 14.2.2. Globus Medical
- 14.2.3. Becton Dickinson (BD)
- 14.2.4. Smith and Nephew
- 14.2.5. Hologi
- 14.2.6. Zimmer Biomet
- 14.2.7. Cook Medical
- 14.2.8. Abbott
- 14.2.9. B. Braun
- 14.2.10. Teleflex
- 14.2.11. Philips Healthcare
- 14.2.12. Terumo Corporation
- 14.2.13. Medtronic
- 14.2.14. Cardinal Health
- 14.2.15. Boston Scientific
- 14.2.16. CONMED Corporation
- 14.2.17. Johnson & Johnson (DePuy Synthes)
- 14.2.18. Siemens Healthineers
- 14.2.19. GE HealthCare
- 14.2.20. Koninklijke Philips
- 14.2.21. NuVasive
- 14.2.22. Arthrex
- 14.2.23. AngioDynamics
- 14.2.24. Others
15. 360 Degree Analyst View
16. Appendix
- 16.1. Research Methodology
- 16.2. References
- 16.3. Abbreviations
- 16.4. Disclaimer
- 16.5. Contact Us
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.